T. Sakamoto et al., RETINAL FUNCTIONAL CHANGE CAUSED BY ADENOVIRAL VECTOR-MEDIATED TRANSFECTION OF LACZ GENE, Human gene therapy, 9(6), 1998, pp. 789-799
Citations number
34
Categorie Soggetti
Genetics & Heredity","Biothechnology & Applied Migrobiology","Medicine, Research & Experimental
We examined the effect of insertion of an exogenous gene on retinal fu
nction to assess the rationale of adenoviral vector-mediated gene tran
sfer for future gene therapy, An adenoviral vector expressing bacteria
l LacZ (AdCALacZ) was injected into the eyes of adult rats either intr
avitreally (group A) or subretinally (group B), and the gene expressio
n and retinal function were thus examined at different time points aft
er gene transfer for 3 weeks. X-Gal histostaining showed that neural r
etinal cells were transfected in group A and that retinal pigment epit
helial cells were transfected in group B. The gene transfer was more e
fficient in group B (54.4% of the fixed retinal area was stained) than
ire group A (10.4%). The electroretinogram (ERG) revealed retinal dys
function in the AdCALacZ-transfected rats even at the stage in which t
he histological damage was not apparent by electron microscopy and imm
unohistochemical studies for cytokeratin, S-100 protein, and glial fib
rillary acidic protein. The ERG change was correlated with the intensi
ty of inflammation, and retinal function recovered to the original lev
el by 3 weeks, along with a diminution of inflammation. Functional cha
nges were more evident in eyes treated with AdCALacZ than in those inf
ected with adenoviral vector with no exogenous gene; however, no histo
logical difference was observed between these groups, indicating that
the insertion of exogenous gene itself affects retinal function. The r
esults showed that different kinds of retinal cells could be gene-tran
sferred by an adenoviral vector, depending on the application method.
The retinal dysfunction caused by each adenoviral transfection method
was caused by inflammation and the insertion of exogenous gene, and th
is retinal dysfunction was recoverable. In future gene therapy, specia
l attention should be given to the method of exogenous gene insertion
in the retina.